Mysticism and Science 2


I just stumbled into this very interesting article and book by Dr. Robert Lanza, the reference in regenerative medicine, about biocentrism, a new notion that is gaining momentum.

Waking Times

A book titled “Biocentrism: How Life and Consciousness Are the Keys to Understanding the Nature of the Universe“ has stirred up the internet, because it contained a notion that life does not end when the body dies, and it can last forever. The author of this publication, scientist Dr. Robert Lanza who was voted the 3rd most important scientist alive by the NY Times, has no doubts that this is possible.

Beyond Time and Space

Lanza is an expert in regenerative medicine and scientific director of Advanced Cell Technology Company. Before, he had been known for his extensive research which dealt with stem cells, he was also famous for several successful experiments on cloning endangered animal species.

But not so long ago, the scientist became involved with physics, quantum mechanics and astrophysics. This explosive mixture has given birth to the new theory of biocentrism, which the professor has been preaching ever since. Biocentrism teaches that life and consciousness are fundamental to the universe. It is consciousness that creates the material universe, not the other way around.

Lanza points to the structure of the universe itself, and that the laws, forces, and constants of the universe appear to be fine-tuned for life, implying intelligence existed prior to matter. He also claims that space and time are not objects or things, but rather tools of our animal understanding. Lanza says that we carry space and time around with us “like turtles with shells.” meaning that when the shell comes off (space and time), we still exist.

The theory implies that death of consciousness simply does not exist. It only exists as a thought because people identify themselves with their body. They believe that the body is going to perish, sooner or later, thinking their consciousness will disappear too. If the body generates consciousness, then consciousness dies when the body dies. But if the body receives consciousness in the same way that a cable box receives satellite signals, then of course consciousness does not end at the death of the physical vehicle. In fact, consciousness exists outside of constraints of time and space. It is able to be anywhere: in the human body and outside of it. In other words, it is non-local in the same sense that quantum objects are non-local.

Lanza also believes that multiple universes can exist simultaneously. In one universe, the body can be dead. And in another it continues to exist, absorbing consciousness which migrated into this universe. This means that a dead person while traveling through the same tunnel ends up not in hell or in heaven, but in a similar world he or she once inhabited, but this time alive. And so on, infinitely. It’s almost like a cosmic Russian doll afterlife effect.

Multiple Worlds

This hope-instilling, but extremely controversial theory by Lanza has many unwitting supporters, not just mere mortals who want to live forever, but also some well-known scientists. These are the physicists and astrophysicists who tend to agree with existence of parallel worlds and who suggest the possibility of multiple universes. Multiverse (multi-universe) is a so-called scientific concept, which they defend. They believe that no physical laws exist which would prohibit the existence of parallel worlds.

The first one was a science fiction writer H.G. Wells who proclaimed in 1895 in his story “The Door in the Wall”. And after 62 years, this idea was developed by Dr. Hugh Everett in his graduate thesis at the Princeton University. It basically posits that at any given moment the universe divides into countless similar instances. And the next moment, these “newborn” universes split in a similar fashion. In some of these worlds you may be present: reading this article in one universe, or watching TV in another.

The triggering factor for these multiplying worlds is our actions, explained Everett. If we make some choices, instantly one universe splits into two with different versions of outcomes.

In the 1980s, Andrei Linde, scientist from the Lebedev’s Institute of physics, developed the theory of multiple universes. He is now a professor at Stanford University. Linde explained: Space consists of many inflating spheres, which give rise to similar spheres, and those, in turn, produce spheres in even greater numbers, and so on to infinity. In the universe, they are spaced apart. They are not aware of each other’s existence. But they represent parts of the same physical universe.

The fact that our universe is not alone is supported by data received from the Planck space telescope. Using the data, scientists have created the most accurate map of the microwave background, the so-called cosmic relic background radiation, which has remained since the inception of our universe. They also found that the universe has a lot of dark recesses represented by some holes and extensive gaps.

Theoretical physicist Laura Mersini-Houghton from the North Carolina University with her colleagues argue: the anomalies of the microwave background exist due to the fact that our universe is influenced by other universes existing nearby. And holes and gaps are a direct result of attacks on us by neighboring universes.


So, there is abundance of places or other universes where our soul could migrate after death, according to the theory of neo-biocentrism. But does the soul exist? Is there any scientific theory of consciousness that could accommodate such a claim? According to Dr. Stuart Hameroff, a near-death experience happens when the quantum information that inhabits the nervous system leaves the body and dissipates into the universe. Contrary to materialistic accounts of consciousness, Dr. Hameroff offers an alternative explanation of consciousness that can perhaps appeal to both the rational scientific mind and personal intuitions.

Consciousness resides, according to Stuart and British physicist Sir Roger Penrose, in the microtubules of the brain cells, which are the primary sites of quantum processing. Upon death, this information is released from your body, meaning that your consciousness goes with it. They have argued that our experience of consciousness is the result of quantum gravity effects in these microtubules, a theory which they dubbed orchestrated objective reduction (Orch-OR).

Consciousness, or at least proto-consciousness is theorized by them to be a fundamental property of the universe, present even at the first moment of the universe during the Big Bang. “In one such scheme proto-conscious experience is a basic property of physical reality accessible to a quantum process associated with brain activity.”

Our souls are in fact constructed from the very fabric of the universe – and may have existed since the beginning of time. Our brains are just receivers and amplifiers for the proto-consciousness that is intrinsic to the fabric of space-time. So is there really a part of your consciousness that is non-material and will live on after the death of your physical body?

Dr Hameroff told the Science Channel’s Through the Wormhole documentary: “Let’s say the heart stops beating, the blood stops flowing, the microtubules lose their quantum state. The quantum information within the microtubules is not destroyed, it can’t be destroyed, it just distributes and dissipates to the universe at large.” Robert Lanza would add here that not only does it exist in the universe, it exists perhaps in another universe.

If the patient is resuscitated, revived, this quantum information can go back into the microtubules and the patient says “I had a near death experience”‘

He adds: “If they’re not revived, and the patient dies, it’s possible that this quantum information can exist outside the body, perhaps indefinitely, as a soul.”

This account of quantum consciousness explains things like near-death experiences, astral projection, out of body experiences, and even reincarnation without needing to appeal to religious ideology. The energy of your consciousness potentially gets recycled back into a different body at some point, and in the mean time it exists outside of the physical body on some other level of reality, and possibly in another universe.



Mysticism and Science


“There is a central order to the universe, an order that can be directly apprehended by the soul in mystical union.”

–Albert Einstein

“Have you often found yourself moved by a fine speech or piece of poetry? Do you sometimes feel a spiritual connection to other people that can’t be explained in words? Do you think mystical experiences are just wishful thinking, or real?

These questions are from the third and final subscale of self-transcendence, which Cloninger call “spiritual acceptance versus rational materialism”.

Individuals who score high for mysticism are fascinated by things that can’t be explained by science. They see a loaf of breed that resembles Jesus or parking space that opens up just in the nick of time as evidence of a higher power. Often they claim to have a “sixth sense,” or extrasensory perception. They believe in miracles.

Low scorers on this subscale are more materialistic and objective. The see an unusual loaf of bread or an unexpected parking opportunity as nothing more than coincidence. They don’t believe in things that can’t be explained scientifically.”

Taken from the book The God Gene by Dean Hamer, a must read, for both scorers.

Friedrich Nietzsche


To understand how a monster thinks, one must become one himself – watch out however not to fall in love in the process, the life of a monster may have appeals you never suspected existed.

“Whoever fights monsters should see to it that in the process he does not become a monster. And if you gaze long enough into an abyss, the abyss will gaze back into you.”

Friedrich Nietzsche


To read more about this exceptional philosopher, click here:

Induced Pluripotent Stem Cells from Bone Marrow-Derived, Peripheral Blood-Derived Hematopoietic Cells and Cord Blood.


As mentioned in a previous article—Public and Private Cord Blood Banking: United We Stand!—umbilical cord blood obtained from the umbilical cord and placenta is a rich source of MSPC’s and HSPC’s; the latter can be used for transplantation to treat a range of malignant, genetic, metabolic, and immune disorders. In fact, it was shown that cord blood HSPC’s are more proliferative and have a greater chance of matching family members than stem cells from bone marrow. Additionally, cord blood is not only widely available and easily accessible—collection is relatively non-invasive, safe and painless—but its derived HSPC’s can even be safely infused when they are an incomplete match for the recipient due to their immunologically naïve quality.

Given the importance of bone marrow and cord blood transplants, the growing numbers of patients requiring them, their growing availability and the quality of those units, one can only wonder if those cells wouldn’t make better candidates for not only inducing pluripotency but also in making pluripotent cells of better quality for clinical use once the difficulties discussed in the previous article are overcome. Indeed, nuclear and mitochondrial mutations in adult stem cells and differentiated somatic lineages appear to accumulate over a lifetime and have been suggested to contribute to aging and cancer formation.

After many efforts, it was found that mature bone marrow derived hematopoietic cells were indeed reprogrammable into pluripotent cells, however it was more difficult than in fibroblast cells. Indeed, they initially required previous transdifferentiation into adherent macrophage-like cells through retroviral overexpression of the myeloid transcription factor CCAAT/enhancer-binding protein-beta. It was later found that less mature bone marrow derived hematopoietic cells were more easily reprogrammable into pluripotent cells.

Peripheral blood derived hematopoietic cells were found to be very bad candidates for inducing pluripotency as they are predominantly nonadherent and slow-cycling. Indeed, researchers were initially simply unable to induce pluripotency unless using G-CSF-mobilization of HSCs, however that was expensive, time consuming and was found to potentially have detrimental effects on individual donors. After many efforts, and without prior stem cell mobilization, several groups were able to induce pluripotency of different mouse and human blood lineages. However, the observed reprogramming efficiencies were typically lower than for fibroblasts.

It was found that cord blood endothelial cells were superior cells for the induction of pluripotent stem cells based on the criteria that they were adherent and actively dividing cells. Furthermore, Giorgetti et al. demonstrated that even frozen cord blood could be used to generate iPSCs with overexpression of OCT4 and SOX2 only. These cells have biological superiority and, thus, could be made available quite rapidly for thousands of patients. For example, children born with cardiac malformations could benefit from CB-iPSC-derived tissue transplants.

In conclusion, it was found that hematopoietic cells from cord blood represent an easily accessible cell source for the derivation of clinically useful iPSCs. Indeed, allogeneic and autologous cord blood from public and commercial CB banking may provide a superior and almost unlimited juvenescent cell source for the production of clinically useful iPSCs.


New Novel Under Review


This is the first picture of me as a published writer (to become a professional writer was a big event for me and one of the most horrible experience in my life! Love writing but hate the business side of it). My new novel is currently under review and soon it will be either put on hold or published. It is about genetic manipulation, conspiracy theories, parascience, psychical abilities and research, secret military programs, etc. Most of it is actually based on real facts but the story itself is of course completely fictional. No matter the result it will  be my last novel as I have decided to dedicate my writing time to research papers and scientific articles.

So to all of my readers, I want to say thank you for having supported me and for having enjoyed my books over the years 🙂


Applying Induced Pluripotent Stem Cells in Treating Brain Diseases


The work conducted by the Yamanaka lab led to the discovery that somatic cells can be reprogrammed into pluripotent cells (hiPSCs’s) by introducing four transcription factors (TFs): Oct4, Sox2, Klf4 and c-Myc—the infamous gene believed to be linked to cancer. Given the highly controversial role of c-Myc, additional studies were conducted to see if those factors could be replaced. It was found that only Oct4 and Sox2 are crucial to induce pluripotency, however, the efficiency suffered significantly. The exact mechanism by which this induction happens is still poorly understood today. It is believed that the expression of the two transcriptions factors among others—that are still being tested—leads to epigenetic modifications in the cell, from which little is known, resulting in inducing a pluripotent state within said cells. This process takes several weeks before yielding a very small percentage of pluripotent cells. This poses a serious problem, which needs to be resolved before using hiPSC’s in therapeutic applications.

Another difficulty, which will also have to be addressed, is the reprogramming technique itself.  Indeed, the three most used reprogramming methods all have flaws that forbid them from being used in therapy.

The initial techniques used were done with lentiviral or retroviral transduction. They were and still are very efficient methods of inducing pluripotency, however, both vectors were found to integrate into the genome. This has for consequence to disrupt the gene at site of entry often leading to tumourigenesis. Furthermore, the expression of the TFs themselves must be regulated, as they are only needed for a set period of time, this leads to problems with differentiation. In order to respond to the difficulties engendered by this method, adenoviral vectors have been developed that do not integrate into the genome. However, the efficiency suffers and prolonged expression of the TFs remains a problem.

Given the difficulties encountered when using viral methods, non-viral methods were developed. Plasmid vectors containing the TFs’ complementary DNA’s were transfected into the cells and resulted for the most part with non-genomic integration. Because of contradictory results, another method was used: fusion of the TFs proteins to a membrane permeable peptide (constructs recombinant cell-penetrating reprogramming proteins). These peptides are broken down by the cell itself and nothing of the constructs remain inside the cells. It is labor intensive however as it requires multiple rounds of addition of recombinant proteins to ensure sufficient presence of the TFs proteins for long enough.  A new method is showing great promises with microRNAs (miRNAs), the regulatory RNAs that repress the expression of a large set of target genes post transcriptionally. It was shown that reprogramming with miRNAs was faster and approximately 100-fold more efficient than with standard viral vectors. However, viral vectors are still used to deliver the miRNAs to the cell. There are ongoing works to overcome this problem with very promising results.

Once the reprogramming techniques perfected, methods to accurately measuring pluripotency must be in place in order to determine if the end product is achieved or not after reprogramming. This in itself is a difficulty as stemness must be clearly defined before being able to qualify an iPSC as having achieved an embryonic stem cell (ESC) like state: stemness is still ill understood and poorly quantified. For those reasons, molecular assays have been created to identify ESC-like condition as well as the epigenetic status of the hiPSCs based on the detection of mRNA associated with pluripotency and promoter activity. However, even after extensive testing it is still difficult to draw conclusive results about the success of the reprogramming technique as even if resemblance to ESCs is attained it might just be that in end, resemblance. Additionally, the efficiency of the reprogramming technique, percentage of viable hiPSC colony forming cells, is usually very low and is dependent on a combination of cell state and reprogramming strategy making the entire process that much more complicated.

Nonetheless, the application of hiPSCs in cell replacement therapy for neurodegenerative diseases including PD, Alzheimer’s Disease and ALS has been the subject of great interest given its potential to repair the damaged brain. And more importantly they can be obtained from the patient own somatic cells and thus bypass immune rejection issues, the ethical issues surrounding ESCs and the very invasive protocols to obtaining neural stem cells.

In the case of PD there were very positive outcome of several studies for developing cell therapies and therefore the use of hiPSCs is being explored extensively. Different labs are trying to optimize in vitro protocols to produce large amounts of functional dopaminergic cells. There are no clinical trials for PD as of yet, but animal studies have shown promising results. Indeed, transplantation performed with iPSC-derived dopaminergic neurons improved motor function in a rat model of PD, and even resulted in an improvement of PD signs, both functionally and behaviorally. There is one major issue however the survival rate of transplanted cells is often low.  Another disease where the use of hiPSCs might be very useful is in vanishing white matter disorder (VWM), a progressive disease in which the white matter of the brain becomes increasingly abnormal and eventually virtually disappears. Indeed, the disease-causing mutations are known and, thus, genetic modification is possible using hiPSCs expanded in sufficient numbers in-vitro before transplantation. Of course the procedure still lacks safety and efficiency and no clinical trials or animal testing is underway as of today since there are no confirmed animal model of the disease yet.

In conclusion, even though hiPSCs show great promises in treating neurodegenerative diseases while avoiding the ethical concerns of ESCs and the problematic immune rejections, there are still many limitations preventing using hiPSCs in clinical settings. Furthermore, even if we overcome the known limitations, we must be aware of potential novel issues arising from using hiPSCs. Indeed, new ethical issues would have to be addressed, such as using patient-specific iPSCs derived cells without the consent of the donor, especially in the production of gametes for reproductive purposes, and, also, we would still need to confirm that differentiated hiPSCs would not trigger an immune response in the patient as well.